,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['mbc', 'destiny04', 'congrat', 'thank you', 'breast', 'astrazeneca']
a landmark day at #asco2022; we are so excited by the #destiny04 data and what it means for the breast cancer community. this is an opportunity to transform the soc in her2-low #mbc both hr + and -. congratulations &amp; thank you to dr. modi, astrazeneca and daiichi sankyo.
Improving patient outcomes with AI-powered pathology.